Professors Rob Howard (×î×¼µÄÁùºÏ²ÊÂÛ̳ Psychiatry) and John Hardy (×î×¼µÄÁùºÏ²ÊÂÛ̳ Queen Square Institute of Neurology) say that it is looking like the once-promising amyloid drugs won’t be the gamechanger for dementia treatments previously hoped for.